Mild G6PD-deficient subjects are recommended a dose of 0.75 mg base/kg one time per week for 8 weeks instead of the standard dose of 0.25–0.5 mg base/kg one time per day for 14 days.2 However, in a clinical setting, these differential dosages can only be implemented if G6PD deficiency status is known. The gene discussed is G6PD; the disease is hyperinsulinemic hypoglycemia, familial, 4.